Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials
- PMID: 21649634
- PMCID: PMC3260523
- DOI: 10.1111/j.1532-5415.2011.03450.x
Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials
Abstract
Objectives: To evaluate the effect of cholinesterase inhibitors (ChEIs) and memantine on the risk of falls, syncope, and related events, defined as fracture and accidental injury.
Design: Meta-analysis of randomized controlled trials that were identified from MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (no language restriction, through July 2009), and manual search.
Setting: Community and nursing homes.
Participants: Participants in fifty-four placebo-controlled randomized trials and extension studies of ChEIs and memantine that reported falls, syncope, and related events in cognitively impaired older adults.
Measurements: Falls, syncope, fracture, and accidental injury.
Results: ChEI use was associated with greater risk of syncope (odds ratio (OR)=1.53, 95% confidence interval (CI)=1.02-2.30) than placebo but not with other events (falls: OR=0.88, 95% CI=0.74-1.04; fracture: OR=1.39, 95% CI=0.75-2.56; accidental injury: OR=1.13, 95% CI=0.87-1.45). Memantine use was associated with fewer fractures (OR=0.21, 95% CI=0.05-0.85) but not with other events (falls: OR=0.92, 95% CI=0.72-1.18; syncope: OR=1.04, 95% CI=0.35-3.04; accidental injury: OR=0.80, 95% CI=0.56-1.12). There was no differential effect according to type and severity of cognitive impairment, residential status, or length of follow-up, although because of underreporting and small number of events, a potential benefit or risk cannot be excluded.
Conclusion: ChEIs may increase the risk of syncope, with no effects on falls, fracture, or accidental injury in cognitively impaired older adults. Memantine may have a favorable effect on fracture, with no effects on other events. More research is needed to confirm the reduction in fractures observed for memantine.
© 2011, Copyright the Authors. Journal compilation © 2011, The American Geriatrics Society.
Figures



Comment in
-
Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures.Evid Based Ment Health. 2011 Nov;14(4):111. doi: 10.1136/ebmh.2011.100170. Epub 2011 Sep 27. Evid Based Ment Health. 2011. PMID: 21954152 No abstract available.
-
ACP Journal Club. Review: cholinesterase inhibitors but not memantine increase syncope in older adults with mild cognitive impairment or dementia.Ann Intern Med. 2011 Nov 15;155(10):JC5-10. doi: 10.7326/0003-4819-155-10-201111150-02010. Ann Intern Med. 2011. PMID: 22084357 No abstract available.
References
-
- van Dijk PT, Meulenberg OG, van de Sande HJ, et al. Falls in dementia patients. Gerontologist. 1993;33:200–204. - PubMed
-
- Morris JC, Rubin EH, Morris EJ, et al. Senile dementia of the Alzheimer's type: An important risk factor for serious falls. J Gerontol. 1987;42:412–417. - PubMed
-
- Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319:1701–1707. - PubMed
-
- Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med. 1997;337:1279–1284. - PubMed